{"_id":"H6GSAibQamzDwbtT1sfYVKW2x0ZoYfPhqFpFcHCfoCdXIhjKOmlk2Y","type":"Investor","logokey":"$WeFTtSjdUDKmJHFLCydrtbFEYJzl61KWWkGZ66KmTv0jJgkxa59iCX.jpeg","name":"Access Biotechnology","subtype":"Corporate VC","lastupdate":"2023-09-19T00:00:00.000Z","update_date":"2023-09-19T00:00:00.000Z","lastModified":"Sep 19, 2023","active":1,"confidence_score":8,"confidence_score_reason":"funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, homepage, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"access-biotechnology","minimal_profile":1,"hide_reason":null,"status":"","fullstatus":null,"hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2022-06-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":null,"iia_supported":null,"currently_iia_supported":null,"alternativenames":null,"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"Access Biotechnology invests in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health.","website":"","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Access Biotechnology invests in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health.","founded":"","education":null,"additional_activities":null,"events":null,"techcommunityinvolvement":null,"exits":[],"funds":[],"portfolio":[{"id":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","name":"Upstream Bio","hidden":true,"raised":"$400M","founded":"2021","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","urlname":"upstream-bio","employees":"11-50","description":"Monoclonal Antibody Drug for Asthma Patients","fundingstage":"B","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":400000000,"companyvisibility":"Private","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Jun 2023","name":"Upstream Bio","amount":200000000,"hidden":true,"islead":0,"country":null,"eventid":"HhRArCFbsmug76Z9n55013qrLcsKa6uZq8j9qgEK20r8oBwKQqEHiV","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","tagline":"Monoclonal Antibody Drug for Asthma Patients","urlname":"/company_page/upstream-bio","companyid":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","isfollowon":1,"companytype":"Startup","eventamount":"$200M","fundingtype":"B Round","investmentid":"aGVDwyLKFwcHsUu6I7nsO98qxOBWHGT3A0kMh9N003krlzmPoVEPNi","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2022","name":"Upstream Bio","amount":200000000,"hidden":true,"islead":0,"country":null,"eventid":"MnK1VMAoT6FIYkGKoDG94miB1mSgfDKodZYw6bouKiFzxq1wEzZ3Wu","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","tagline":"Monoclonal Antibody Drug for Asthma Patients","urlname":"/company_page/upstream-bio","companyid":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","isfollowon":0,"companytype":"Startup","eventamount":"$200M","fundingtype":"A Round","investmentid":"A3MomBFcrdiUQAoBApYFvVAkZNUG5Gd8pGnotRz3lgV1dsW4tMVi8P","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[],"tags":[],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[]},"headquarter_address":null,"news":[],"newsNumber":0,"mediagallery":[],"biverification":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2023-09-19T00:00:00.000Z","recentupdates":[{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:45:48.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:45:48.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:45:48.000000","last_name":"Eblagon","first_name":"Matan"}],"rounds_per_sector":[{"count":2,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"A Round"},{"count":1,"isfollowon":1,"fundingStage":"B Round"}],"investment_rounds_over_time":[{"year":2022,"month":6,"record_count":1},{"year":2023,"month":6,"record_count":1}],"portfolio_companies_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2022,"month":6,"record_count":1}],"exits_over_time":null,"exits_by_sector":null,"affiliatedOrganizations":null,"timeline":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Corporate VC","parsedName":"Access Biotechnology","logourl":"https://storage.googleapis.com/clean-finder-353810/$WeFTtSjdUDKmJHFLCydrtbFEYJzl61KWWkGZ66KmTv0jJgkxa59iCX.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$WeFTtSjdUDKmJHFLCydrtbFEYJzl61KWWkGZ66KmTv0jJgkxa59iCX.jpeg","teamMembersNumber":0,"section":null,"sectionParams":"","queryParams":"","seoabout":"Access Biotechnology invests in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human heal...","seoTitle":"Foreign Corporate VC","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"A Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"B Round\",\"newInvestments\":0,\"followOnInvestments\":1}],\"investmentRoundsBySector\":[{\"count\":2,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[],\"exitsBySector\":[]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$200M - $200M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}